Clinical trial
MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease…
NCT00362024 · Merck Sharp & Dohme LLC, Industry · Terminated
Key facts
| NCT number | NCT00362024 |
|---|---|
| Title | MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease (0952-004)(COMPLETED) |
| Official title | MK0952 in Patients With Mild-to-Moderate Alzheimer's Disease |
| Lead sponsor | Merck Sharp & Dohme LLC, Industry |
| Status | Terminated |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Alzheimer's Disease |
| Intervention type | Drug |
| Interventions | MK0952, Comparator: Placebo |
| Enrollment | 24 |
| Start date | Nov 1, 2006 |
| Primary completion | Nov 1, 2007 |
| Completion | Nov 1, 2007 |
| First posted | Aug 9, 2006 |
| Last update posted | May 16, 2016 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: